Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-589-7 | CAS number: 1897-52-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 5 May 1992 to 19 May 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results. The study report was conclusive, done to a valid guideline and the study was conducted under GLP conditions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- yes
- Remarks:
- ( the protocol described that the int. doc. no. of this study was 56645/13/92 rather than 56645/37/92) This deviation is not considered to have affected the integrity of the study or its results.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 2,6-difluorobenzonitrile
- EC Number:
- 217-589-7
- EC Name:
- 2,6-difluorobenzonitrile
- Cas Number:
- 1897-52-5
- Molecular formula:
- C7H3F2N
- IUPAC Name:
- 2,6-difluorobenzonitrile
- Details on test material:
- - Physical state: a white paste
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan/CPB, Zeist, The Netherlands
- Weight at study initiation (animal arrival): Male rats weighed 175-200g and females 150-175g
- Housing: Individually (application period); 2-3 animals per cage (all other times)
- Diet: ad libitum (standard laboratory diet RHM-TM, Hope Farms, Woerden, The Netherlands)
- Water: ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (ºC): 19-23 ºC
- Humidity (%): 40-65%
- Air changes (per hr): approximately 16 changes
- Photoperiod (hrs dark / hrs light): 12 hrs dark, 12 hrs light (artificial)
IN-LIFE DATES: 5th May 1992 - 19th May 1992
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- test material was melted at 32 ºC prior to application
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Hair from the back and flanks of the animals was removed with an electric clipper
- Type of wrap used: The test material was applied over a strip of gauze of about 15 cm². The patch was heated under an incandescent lamp to melt the test material so that it could be applied uniformly over the patch. The gauze was covered with an occlusive Blenderm tape of about 5 x 10 cm, on a wider strip of plaster. The total patch with test material was applied on the back and flanks of each animal and help in place with strips of plaster.
- Animal restraint during test material application: To prevent damaging of the patches, the rats were fitted with collars during the application period. After 24 hours the collars were removed.
REMOVAL OF TEST SUBSTANCE: After 24 hours of exposure the gauze patches were peeled off under light ether anaesthesia. The skin was wiped to remove any remaining test material.
TEST MATERIAL
- Amount(s) applied: The amount of test material was calculated for each animal according to its weight at the time of dosing. All animals were treated with 2000 mg/kg of test material. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg body weight
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observation and weighing: Prior to the start of the study, all rats were examined for any skin lesions. The animals were observed at 1, 3, 5, 25 and29 hours after application and thereafter once on each day until the end of the study. The animals were weighed one day before dosing (day -1), on the day of dosing (day 0), and at 2, 7 and 14 days after treatment.
- Necropsy of survivors performed: At the end of the study all animals were killed by ether inhalation and an autopsy was performed that included inspection of the external appearance, the cervical area, the thoracic and abdominal cavities.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 other: mg/kg
- Based on:
- test mat.
- Mortality:
- None of the animals dies over the course of the study.
- Clinical signs:
- other: During the application period, chromodacryorrhoea and dirty noses were noticed from 1 hour after start of the application up to 24 hours after treatment in both males and females. Upon removal of the collars these signs disappeared. In both males and fem
- Gross pathology:
- At autopsy 14 days after treatment, 4 male and 3 female rats had a few red spots on their lungs and thymus. These findings were considered not to be treatment-related. No macroscopic abnormalities were noted that could be considered to be treatment-related.
Any other information on results incl. tables
Table 1: Body Weights (g)
Sex | Animal No. | Day | ||||
-1 | 0 | 2 | 7 | 14 | ||
M | 1 | 203 | 216 | 209 | 236 | 259 |
2 | 212 | 221 | 214 | 238 | 259 | |
3 | 212 | 229 | 202 | 236 | 267 | |
4 | 200 | 209 | 203 | 229 | 262 | |
5 | 197 | 210 | 196 | 211 | 232 | |
Mean | 204.8 | 217.0 | 204.8 | 230.0 | 255.8 | |
F | 1 | 179 | 174 | 175 | 182 | 194 |
2 | 183 | 191 | 173 | 190 | 208 | |
3 | 178 | 185 | 172 | 186 | 202 | |
4 | 185 | 194 | 179 | 188 | 190 | |
5 | 159 | 170 | 164 | 176 | 190 | |
Mean | 176.8 | 182.8 | 172.6 | 184.4 | 196.8 |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the study, the acute dermal median lethal dose of the test material was estimated to be in excess of 2000 mg/kg in rats. The study is considered to be reliable, relevant and adequate for risk assessment and classification and labelling purposes.
- Executive summary:
The acute dermal toxicity of the test material was determined in accordance with standard guideline EU Method B.3. During the study five male and five female rats received a single dermal application of 2000 mg/kg of the test material. Animals were assessed over a 14 day observation period for any signs of systemic toxicity. None of the animals died during the study and the clinical signs noted were mostly indicative of effects on motor coordination (abnormal gait and posture). In addition, signs indicative of effects on the autonomic nervous system were observed in one male and female and on the central nervous system in one female only. Time of onset of signs was between 5 and 25 hours after application. Signs were slight to moderate in intensity and had disappeared after 29 hours in males and 3 days in females. After dermal application of the test material the animals showed a decrease in body weights in the first few days of the study. Thereafter body weight gains appeared to be normal. There were no macroscopic abnormalities at examination post-mortem. The acute median lethal dose of the test material was estimated to be in excess of 2000 mg/kg in both male and female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.